APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Liposome Encapsulation Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liposome Encapsulation Services Market Analysis and Forecast 2026-2032

Report ID 17417737026 March 2026197 pages

Choose your research edition.

Industry ResearchLiposome Encapsulation Services Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposome Encapsulation Services Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Liposome Encapsulation Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposome Encapsulation Services Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Liposome Encapsulation Services Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Liposome Encapsulation Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Liposome Encapsulation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liposome Encapsulation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liposome Encapsulation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liposome Encapsulation Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Liposome Encapsulation Services include BOC Sciences, Evonik, Danaher, Merck, Creative Biolabs, Polymun Scientific, Lonza, CordenPharma and Baxter BioPharma Solutions, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Liposome Encapsulation Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liposome Encapsulation Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Liposome Encapsulation Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liposome Encapsulation Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liposome Encapsulation Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Liposome Encapsulation Services revenue, projected growth trends, production technology, application and end-user industry.

Liposome Encapsulation Services Segment by Company

BOC Sciences

Evonik

Danaher

Merck

Creative Biolabs

Polymun Scientific

Lonza

CordenPharma

Baxter BioPharma Solutions

Luye Pharma

GMPriority Pharma

Liposome Encapsulation Services Segment by Type

Hydrophilic Molecules

Hydrophobic Molecules

Macromolecules/Nucleic Acids

Others

Liposome Encapsulation Services Segment by Application

Pharmaceutical

Nutraceutical

Cosmetic

Liposome Encapsulation Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Encapsulation Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposome Encapsulation Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Encapsulation Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Liposome Encapsulation Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Liposome Encapsulation Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Encapsulation Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liposome Encapsulation Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hydrophilic Molecules Major Player Table 3. Hydrophobic Molecules Major Player Table 4. Macromolecules/Nucleic Acids Major Player Table 5. Others Major Player Table 6. Global Liposome Encapsulation Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Major Player Table 8. Nutraceutical Major Player Table 9. Cosmetic Major Player Table 10. Liposome Encapsulation Services Industry Trends Table 11. Liposome Encapsulation Services Industry Drivers Table 12. Liposome Encapsulation Services Industry Opportunities and Challenges Table 13. Liposome Encapsulation Services Industry Restraints Table 14. Global Liposome Encapsulation Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Liposome Encapsulation Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Liposome Encapsulation Services Market Share by Region (2021-2026) Table 17. Global Liposome Encapsulation Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Liposome Encapsulation Services Market Share by Region (2027-2032) Table 19. Global Liposome Encapsulation Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Liposome Encapsulation Services Revenue Market Share by Players (2021-2026) Table 21. Global Liposome Encapsulation Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Liposome Encapsulation Services Key Players Headquarters & Area Served Table 23. Global Liposome Encapsulation Services Players, Product Type & Application Table 24. Global Liposome Encapsulation Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Liposome Encapsulation Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Liposome Encapsulation Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Liposome Encapsulation Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Liposome Encapsulation Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Liposome Encapsulation Services Revenue Market Share by Type (2021-2026) Table 31. Global Liposome Encapsulation Services Revenue Market Share by Type (2027-2032) Table 32. Global Liposome Encapsulation Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Liposome Encapsulation Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Liposome Encapsulation Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Liposome Encapsulation Services Revenue Market Share by Application (2021-2026) Table 36. Global Liposome Encapsulation Services Revenue Market Share by Application (2027-2032) Table 37. BOC Sciences Company Information Table 38. BOC Sciences Business Overview Table 39. BOC Sciences Liposome Encapsulation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. BOC Sciences Liposome Encapsulation Services Product Portfolio Table 41. BOC Sciences Recent Development Table 42. Evonik Company Information Table 43. Evonik Business Overview Table 44. Evonik Liposome Encapsulation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Evonik Liposome Encapsulation Services Product Portfolio Table 46. Evonik Recent Development Table 47. Danaher Company Information Table 48. Danaher Business Overview Table 49. Danaher Liposome Encapsulation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Danaher Liposome Encapsulation Services Product Portfolio Table 51. Danaher Recent Development Table 52. Merck Company Information Table 53. Merck Business Overview Table 54. Merck Liposome Encapsulation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Merck Liposome Encapsulation Services Product Portfolio Table 56. Merck Recent Development Table 57. Creative Biolabs Company Information Table 58. Creative Biolabs Business Overview Table 59. Creative Biolabs Liposome Encapsulation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Creative Biolabs Liposome Encapsulation Services Product Portfolio Table 61. Creative Biolabs Recent Development Table 62. Polymun Scientific Company Information Table 63. Polymun Scientific Business Overview Table 64. Polymun Scientific Liposome Encapsulation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Polymun Scientific Liposome Encapsulation Services Product Portfolio Table 66. Polymun Scientific Recent Development Table 67. Lonza Company Information Table 68. Lonza Business Overview Table 69. Lonza Liposome Encapsulation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Lonza Liposome Encapsulation Services Product Portfolio Table 71. Lonza Recent Development Table 72. CordenPharma Company Information Table 73. CordenPharma Business Overview Table 74. CordenPharma Liposome Encapsulation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. CordenPharma Liposome Encapsulation Services Product Portfolio Table 76. CordenPharma Recent Development Table 77. Baxter BioPharma Solutions Company Information Table 78. Baxter BioPharma Solutions Business Overview Table 79. Baxter BioPharma Solutions Liposome Encapsulation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Baxter BioPharma Solutions Liposome Encapsulation Services Product Portfolio Table 81. Baxter BioPharma Solutions Recent Development Table 82. Luye Pharma Company Information Table 83. Luye Pharma Business Overview Table 84. Luye Pharma Liposome Encapsulation Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Luye Pharma Liposome Encapsulation Services Product Portfolio Table 86. Luye Pharma Recent Development Table 87. GMPriority Pharma Company Information Table 88. GMPriority Pharma Business Overview Table 89. GMPriority Pharma Liposome Encapsulation Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. GMPriority Pharma Liposome Encapsulation Services Product Portfolio Table 91. GMPriority Pharma Recent Development Table 92. North America Liposome Encapsulation Services Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Liposome Encapsulation Services Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Liposome Encapsulation Services Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Liposome Encapsulation Services Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Liposome Encapsulation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Liposome Encapsulation Services Revenue by Country (2021-2026) & (US$ Million) Table 98. North America Liposome Encapsulation Services Revenue by Country (US$ Million) & (2027-2032) Table 99. Europe Liposome Encapsulation Services Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Liposome Encapsulation Services Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Liposome Encapsulation Services Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Liposome Encapsulation Services Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Liposome Encapsulation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Liposome Encapsulation Services Revenue by Country (2021-2026) & (US$ Million) Table 105. Europe Liposome Encapsulation Services Revenue by Country (US$ Million) & (2027-2032) Table 106. China Liposome Encapsulation Services Revenue by Type (2021-2026) & (US$ Million) Table 107. China Liposome Encapsulation Services Revenue by Type (2027-2032) & (US$ Million) Table 108. China Liposome Encapsulation Services Revenue by Application (2021-2026) & (US$ Million) Table 109. China Liposome Encapsulation Services Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Liposome Encapsulation Services Revenue by Type (2021-2026) & (US$ Million) Table 111. Asia Liposome Encapsulation Services Revenue by Type (2027-2032) & (US$ Million) Table 112. Asia Liposome Encapsulation Services Revenue by Application (2021-2026) & (US$ Million) Table 113. Asia Liposome Encapsulation Services Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Liposome Encapsulation Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia Liposome Encapsulation Services Revenue by Region (US$ Million) & (2021-2026) Table 116. Asia Liposome Encapsulation Services Revenue by Region (US$ Million) & (2027-2032) Table 117. SAMEA Liposome Encapsulation Services Revenue by Type (2021-2026) & (US$ Million) Table 118. SAMEA Liposome Encapsulation Services Revenue by Type (2027-2032) & (US$ Million) Table 119. SAMEA Liposome Encapsulation Services Revenue by Application (2021-2026) & (US$ Million) Table 120. SAMEA Liposome Encapsulation Services Revenue by Application (2027-2032) & (US$ Million) Table 121. SAMEA Liposome Encapsulation Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. SAMEA Liposome Encapsulation Services Revenue by Country (2021-2026) & (US$ Million) Table 123. SAMEA Liposome Encapsulation Services Revenue by Country (US$ Million) & (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Liposome Encapsulation Services Image Figure 2. Global Liposome Encapsulation Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposome Encapsulation Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hydrophilic Molecules Image Figure 5. Hydrophobic Molecules Image Figure 6. Macromolecules/Nucleic Acids Image Figure 7. Others Image Figure 8. Global Liposome Encapsulation Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Liposome Encapsulation Services Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Image Figure 11. Nutraceutical Image Figure 12. Cosmetic Image Figure 13. Global Liposome Encapsulation Services Market Size (US$ Million) & (2021-2032) Figure 14. Global Liposome Encapsulation Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Liposome Encapsulation Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Liposome Encapsulation Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Liposome Encapsulation Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Liposome Encapsulation Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Liposome Encapsulation Services Revenue Market Share by Type (2021-2032) Figure 21. Global Liposome Encapsulation Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Liposome Encapsulation Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Liposome Encapsulation Services Revenue Market Share by Application (2021-2032) Figure 24. North America Liposome Encapsulation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Liposome Encapsulation Services Revenue Share by Type (2021-2032) Figure 26. North America Liposome Encapsulation Services Revenue Share by Application (2021-2032) Figure 27. North America Liposome Encapsulation Services Revenue Share by Country (2021-2032) Figure 28. United States Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Liposome Encapsulation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Liposome Encapsulation Services Revenue Share by Type (2021-2032) Figure 33. Europe Liposome Encapsulation Services Revenue Share by Application (2021-2032) Figure 34. Europe Liposome Encapsulation Services Revenue Share by Country (2021-2032) Figure 35. Germany Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Liposome Encapsulation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Liposome Encapsulation Services Revenue Share by Type (2021-2032) Figure 45. China Liposome Encapsulation Services Revenue Share by Application (2021-2032) Figure 46. Asia Liposome Encapsulation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Liposome Encapsulation Services Revenue Share by Type (2021-2032) Figure 48. Asia Liposome Encapsulation Services Revenue Share by Application (2021-2032) Figure 49. Asia Liposome Encapsulation Services Revenue Share by Region (2021-2032) Figure 50. Japan Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Liposome Encapsulation Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Liposome Encapsulation Services Revenue Share by Type (2021-2032) Figure 58. SAMEA Liposome Encapsulation Services Revenue Share by Application (2021-2032) Figure 59. SAMEA Liposome Encapsulation Services Revenue Share by Country (2021-2032) Figure 60. Brazil Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Liposome Encapsulation Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hydrophilic Molecules
  • Hydrophobic Molecules
  • Macromolecules/Nucleic Acids
  • Others
Applications
  • Pharmaceutical
  • Nutraceutical
  • Cosmetic
Companies covered
  • BOC Sciences
  • Evonik
  • Danaher
  • Merck
  • Creative Biolabs
  • Polymun Scientific
  • Lonza
  • CordenPharma
  • Baxter BioPharma Solutions
  • Luye Pharma
  • GMPriority Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liposome Encapsulation Services Market by Type
  3. 1.2.1 Global Liposome Encapsulation Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hydrophilic Molecules
  5. 1.2.3 Hydrophobic Molecules
  6. 1.2.4 Macromolecules/Nucleic Acids
  7. 1.2.5 Others
  8. 1.3 Liposome Encapsulation Services Market by Application
  9. 1.3.1 Global Liposome Encapsulation Services Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical
  11. 1.3.3 Nutraceutical
  12. 1.3.4 Cosmetic
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Liposome Encapsulation Services Market Dynamics
  1. 2.1 Liposome Encapsulation Services Industry Trends
  2. 2.2 Liposome Encapsulation Services Industry Drivers
  3. 2.3 Liposome Encapsulation Services Industry Opportunities and Challenges
  4. 2.4 Liposome Encapsulation Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Liposome Encapsulation Services Market Perspective (2021-2032)
  2. 3.2 Global Liposome Encapsulation Services Growth Trends by Region
  3. 3.2.1 Global Liposome Encapsulation Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liposome Encapsulation Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Liposome Encapsulation Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Liposome Encapsulation Services Revenue by Players
  2. 4.1.1 Global Liposome Encapsulation Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Liposome Encapsulation Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Liposome Encapsulation Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liposome Encapsulation Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Liposome Encapsulation Services Key Players Headquarters & Area Served
  7. 4.4 Global Liposome Encapsulation Services Players, Product Type & Application
  8. 4.5 Global Liposome Encapsulation Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Liposome Encapsulation Services Market CR5 and HHI
  11. 4.6.3 2025 Liposome Encapsulation Services Tier 1, Tier 2, and Tier 3
5 Liposome Encapsulation Services Market Size by Type
  1. 5.1 Global Liposome Encapsulation Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Liposome Encapsulation Services Revenue by Type (2021-2032)
  3. 5.3 Global Liposome Encapsulation Services Revenue Market Share by Type (2021-2032)
6 Liposome Encapsulation Services Market Size by Application
  1. 6.1 Global Liposome Encapsulation Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Liposome Encapsulation Services Revenue by Application (2021-2032)
  3. 6.3 Global Liposome Encapsulation Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BOC Sciences
  2. 7.1.1 BOC Sciences Company Information
  3. 7.1.2 BOC Sciences Business Overview
  4. 7.1.3 BOC Sciences Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BOC Sciences Liposome Encapsulation Services Product Portfolio
  6. 7.1.5 BOC Sciences Recent Developments
  7. 7.2 Evonik
  8. 7.2.1 Evonik Company Information
  9. 7.2.2 Evonik Business Overview
  10. 7.2.3 Evonik Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Evonik Liposome Encapsulation Services Product Portfolio
  12. 7.2.5 Evonik Recent Developments
  13. 7.3 Danaher
  14. 7.3.1 Danaher Company Information
  15. 7.3.2 Danaher Business Overview
  16. 7.3.3 Danaher Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Danaher Liposome Encapsulation Services Product Portfolio
  18. 7.3.5 Danaher Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Merck Liposome Encapsulation Services Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 Creative Biolabs
  26. 7.5.1 Creative Biolabs Company Information
  27. 7.5.2 Creative Biolabs Business Overview
  28. 7.5.3 Creative Biolabs Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Biolabs Liposome Encapsulation Services Product Portfolio
  30. 7.5.5 Creative Biolabs Recent Developments
  31. 7.6 Polymun Scientific
  32. 7.6.1 Polymun Scientific Company Information
  33. 7.6.2 Polymun Scientific Business Overview
  34. 7.6.3 Polymun Scientific Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Polymun Scientific Liposome Encapsulation Services Product Portfolio
  36. 7.6.5 Polymun Scientific Recent Developments
  37. 7.7 Lonza
  38. 7.7.1 Lonza Company Information
  39. 7.7.2 Lonza Business Overview
  40. 7.7.3 Lonza Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Lonza Liposome Encapsulation Services Product Portfolio
  42. 7.7.5 Lonza Recent Developments
  43. 7.8 CordenPharma
  44. 7.8.1 CordenPharma Company Information
  45. 7.8.2 CordenPharma Business Overview
  46. 7.8.3 CordenPharma Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 CordenPharma Liposome Encapsulation Services Product Portfolio
  48. 7.8.5 CordenPharma Recent Developments
  49. 7.9 Baxter BioPharma Solutions
  50. 7.9.1 Baxter BioPharma Solutions Company Information
  51. 7.9.2 Baxter BioPharma Solutions Business Overview
  52. 7.9.3 Baxter BioPharma Solutions Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Baxter BioPharma Solutions Liposome Encapsulation Services Product Portfolio
  54. 7.9.5 Baxter BioPharma Solutions Recent Developments
  55. 7.10 Luye Pharma
  56. 7.10.1 Luye Pharma Company Information
  57. 7.10.2 Luye Pharma Business Overview
  58. 7.10.3 Luye Pharma Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Luye Pharma Liposome Encapsulation Services Product Portfolio
  60. 7.10.5 Luye Pharma Recent Developments
  61. 7.11 GMPriority Pharma
  62. 7.11.1 GMPriority Pharma Company Information
  63. 7.11.2 GMPriority Pharma Business Overview
  64. 7.11.3 GMPriority Pharma Liposome Encapsulation Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 GMPriority Pharma Liposome Encapsulation Services Product Portfolio
  66. 7.11.5 GMPriority Pharma Recent Developments
8 North America
  1. 8.1 North America Liposome Encapsulation Services Revenue (2021-2032)
  2. 8.2 North America Liposome Encapsulation Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Liposome Encapsulation Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Liposome Encapsulation Services Revenue by Type (2027-2032)
  5. 8.3 North America Liposome Encapsulation Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Liposome Encapsulation Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Liposome Encapsulation Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Liposome Encapsulation Services Revenue by Application (2027-2032)
  9. 8.5 North America Liposome Encapsulation Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Liposome Encapsulation Services Revenue by Country
  11. 8.6.1 North America Liposome Encapsulation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Liposome Encapsulation Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Liposome Encapsulation Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Liposome Encapsulation Services Revenue (2021-2032)
  2. 9.2 Europe Liposome Encapsulation Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Liposome Encapsulation Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Liposome Encapsulation Services Revenue by Type (2027-2032)
  5. 9.3 Europe Liposome Encapsulation Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Liposome Encapsulation Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Liposome Encapsulation Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Liposome Encapsulation Services Revenue by Application (2027-2032)
  9. 9.5 Europe Liposome Encapsulation Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Liposome Encapsulation Services Revenue by Country
  11. 9.6.1 Europe Liposome Encapsulation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Liposome Encapsulation Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Liposome Encapsulation Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Liposome Encapsulation Services Revenue (2021-2032)
  2. 10.2 China Liposome Encapsulation Services Revenue by Type (2021-2032)
  3. 10.2.1 China Liposome Encapsulation Services Revenue by Type (2021-2026)
  4. 10.2.2 China Liposome Encapsulation Services Revenue by Type (2027-2032)
  5. 10.3 China Liposome Encapsulation Services Revenue Share by Type (2021-2032)
  6. 10.4 China Liposome Encapsulation Services Revenue by Application (2021-2032)
  7. 10.4.1 China Liposome Encapsulation Services Revenue by Application (2021-2026)
  8. 10.4.2 China Liposome Encapsulation Services Revenue by Application (2027-2032)
  9. 10.5 China Liposome Encapsulation Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liposome Encapsulation Services Revenue (2021-2032)
  2. 11.2 Asia Liposome Encapsulation Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Liposome Encapsulation Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Liposome Encapsulation Services Revenue by Type (2027-2032)
  5. 11.3 Asia Liposome Encapsulation Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Liposome Encapsulation Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Liposome Encapsulation Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Liposome Encapsulation Services Revenue by Application (2027-2032)
  9. 11.5 Asia Liposome Encapsulation Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Liposome Encapsulation Services Revenue by Country
  11. 11.6.1 Asia Liposome Encapsulation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Liposome Encapsulation Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Liposome Encapsulation Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liposome Encapsulation Services Revenue (2021-2032)
  2. 12.2 SAMEA Liposome Encapsulation Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Liposome Encapsulation Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Liposome Encapsulation Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Liposome Encapsulation Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Liposome Encapsulation Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Liposome Encapsulation Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Liposome Encapsulation Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Liposome Encapsulation Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Liposome Encapsulation Services Revenue by Country
  11. 12.6.1 SAMEA Liposome Encapsulation Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Liposome Encapsulation Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Liposome Encapsulation Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst